364
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Role of Thoracoscore and ESOS in Prediction of Outcomes after Thoracic Surgeries

, ORCID Icon, , &
Pages 557-562 | Received 09 May 2023, Accepted 06 Jul 2023, Published online: 12 Jul 2023
 

ABSTRACT

Background

The use of scores in thoracic surgery has been done recently. European Society Objective Score (ESOS) and Thoracoscore are the most popular scores used in thoracic operations. This work aimed to compare ESOS and Thoracoscore’s ability in predicting the mortality after thoracic surgery.

Methods

This retrospective study involved 282 cases who were admitted to thoracic surgery unit, Tanta University Hospitals and other hospitals whose Thoracoscore and ESOS were calculated from January 2017 to December 2022.

Results

Mortality rate at 30 days postoperative was 7.44% in our study. Pneumonectomy and MV (mechanical ventilation) were significantly associated with mortality (P value < 0.001). Thoracoscore can predict mortality (P value = 0.004 and AUC = 0.629) with 61.9% sensitivity, 56.70% specificity, 10.3% positive predictive value (PPV), and 94.9% negative predictive value(NPV). ESOS can predict mortality (P value = 0.006 and AUC = 0.662) with 85.71% sensitivity, 37.55% specificity, 9.9% PPV and 97% NPV. ESOS was an independent significant predictor for mortality while Thoracoscore was not.

Conclusions

ESOS and Thoracoscore are applicable tools in predicting the mortality after thoracic surgeries. However, ESOS is more sensitive and more specific.

Acknowledgments

Nothing to declare.

Disclosure statement

None of the authors has a conflict of interest.

Availability of data and material

The datasets utilized and/or analyzed for this work are accessible as MS Excel files (.xlsx) from the corresponding author upon reasonable request.

Sponsors and funding sources

There are none to be declared.

Ethical approval and protocol registration

The study was done after approval by the Faculty of Medicine’s Ethical Committee at Tanta University (approval code: 36264PR66/1/23) and all cases provided informed consent.

Additional information

Funding

No funding was obtained for this investigation.